Public Data
16 samples
MafB, WDR77, and ß-catenin interact with each other and have similar genome association profiles [RNA-seq]
Accession: SRP357459
Published: 2022 in PLoS One
cell line
bioactive entity
breast
Public Data
6 samples
Nigroquinone C (3) attenuate MDA-MB-231 cells
Accession: SRP352642
Published: 2022
cell line
bioactive entity
breast
breast cancer
Public Data
5 samples
Osmotic controlling defection provides a new avenue for malignancy therapy
Accession: SRP341535
Published: 2022
cell line
other
liver
hepatocellular carcinoma
Public Data
12 samples
RNA-seq of shControl and shRUNX1-ETO Kasumi-1 cells
Accession: ERP121468
Published: 2022
cell line
gene, gene: shrna
blood
acute myeloblastic leukemia with maturation
Public Data
12 samples
Bulk RNA-seq of cerebral organoids investigating the role of CHD8 in cortical development
Accession: ERP126012
Published: 2022
organoid
gene, gene: crispr
blastocyst
normal
Public Data
9 samples
RNA-seq of human adipose tissue macrophage subtypes in obesity
Accession: SRP348617
Published: 2022 in JCI Insight
primary cells
omental fat pad
obesity disorder
Public Data
41 samples
The use of a complex tetra-culture alveolar model to study the toxicological effects of gold nanoparticles with different physicochemical properties
Accession: SRP339286
Published: 2022
cell line
bioactive entity
lung
Public Data
13 samples
Variation of UCB CD34+ in erythroid differentiation potential
Accession: SRP336990
Published: 2022
primary cells
blood
Public Data
18 samples
Circular RNA YPEL2 promotes cell proliferation, migration and invasion as a biomaker in cervical cancer
Accession: SRP315892
Published: 2022 in Genes (Basel)
cell line, primary tissue
gene, gene: sirna
uterine cervix
cervical cancer
Public Data
6 samples
A novel regulatory mechanism of U2 spliceosome proteostasis that controls the transcriptome and therapy response in cancer [TTseq_CUTLL1_E7107_15min]
Accession: SRP312774
Published: 2022 in Sci Adv
cell line
bioactive entity
pleural effusion
leukemia
Public Data
6 samples
A novel regulatory mechanism of U2 spliceosome proteostasis that controls the transcriptome and therapy response in cancer [TTseq_CUTLL1_E7107_24hr]
Accession: SRP312773
Published: 2022 in Sci Adv
cell line
bioactive entity
pleural effusion
leukemia
Public Data
6 samples
A novel regulatory mechanism of U2 spliceosome proteostasis that controls the transcriptome and therapy response in cancer [RNAseq_CUTLL1_shSF3B1_MapR]
Accession: SRP312772
Published: 2022 in Sci Adv
cell line
gene, gene: shrna
pleural effusion
leukemia
Public Data
12 samples
A novel regulatory mechanism of U2 spliceosome proteostasis that controls the transcriptome and therapy response in cancer [RNAseq_CUTLL1_E7107_NMDi]
Accession: SRP312771
Published: 2022 in Sci Adv
cell line
bioactive entity
pleural effusion
leukemia
Public Data
12 samples
A novel regulatory mechanism of U2 spliceosome proteostasis that controls the transcriptome and therapy response in cancer [RNAseq_CUTLL1_E7107_15min_30m]
Accession: SRP312770
Published: 2022 in Sci Adv
cell line
bioactive entity
pleural effusion
T-cell acute lymphoblastic leukemia
Public Data
9 samples
A novel regulatory mechanism of U2 spliceosome proteostasis that controls the transcriptome and therapy response in cancer [RNAseq_CUTLL1_E7107_24hr]
Accession: SRP312769
Published: 2022 in Sci Adv
cell line
bioactive entity
pleural effusion
T-cell acute lymphoblastic leukemia